Indie Sci-Fi: Pharma Ethics Roadmap for 2026
Indie sci-fi warns pharma on ethics for 2026. See how fictional futures reveal biotech dangers and urge equitable drug access.
Indie sci-fi warns pharma on ethics for 2026. See how fictional futures reveal biotech dangers and urge equitable drug access.
Yale launches new $2.5M initiatives in 2026 to foster dialogue among specialized groups. Will these programs truly bridge communication gaps?
Yale's $40 billion endowment. Why are university niche museums at risk in 2026? Learn what's happening and what's next.
Indie artist Elias Vance faces a heart condition, exposing healthcare gaps for musicians. Learn why drug research and artist advocacy matter.
Yale is archiving online fandoms using Archive-It. Learn why preserving digital culture matters and what challenges remain for 2026.
A 2038 gene therapy trial for Lp(a) failed with severe side effects. What went wrong, and how does it reshape medical ethics and drug development?
Yale faces declining literature enrollment as students flock to TikTok and superhero studies. See how universities adapt curricula for 2026.
Yale faces a 42% risk of losing digital content by 2026. See why institutions struggle to save niche data and what it costs: $1.50 per GB annually.
Why do drug trials fail? Learn how past medical tragedies like Thalidomide still shape ethical oversight in 2026, ensuring patient safety.
Yale's 2026 plan shifts 15% of new faculty to niche studies. See why this changes higher education, driven by market demand and new funding models.